[PDF] Top 20 Influence of ischemia on visual function in patients with branch retinal vein occlusion and macular edema

... consecutive patients with a mean age of ...months). Patients were diagnosed as having hyperten- sion if their systolic blood pressure was $140 mm Hg and diastolic blood pressure was ... See full document

... for visual acuity, macu- lar sensitivity within the central 4°, 10°, and 20° fields was not significantly worse in the SRD group than in the CME ...no influence on macular sensitivity because there ... See full document

... the patients. We included patients who had best corrected visual acuity (BCVA) worse than ...treatment. Patients were excluded from the study if they had initial findings or medical history of ... See full document

... BRVO patients [33], which suggests that levels of cytokines in the vitreous fluid are not deter- mined by disruption of the blood-retinal ...the influence of the outer photoreceptor layer on the ... See full document

... of retinal VEGF mRNA expression after laser photocoagulation were confined to RPE cells in miniature pigs, with reduced mRNA expression immedi- ately after photocoagulation and a return to normal by 42 ...of ... See full document

... significant influence on the visual outcome according to multivariate analysis, although the vitreous VEGF level did ...the visual prognosis after ... See full document

... our patients the temporal delay from diagnosis to treatment initiation did not influence visual outcome (figure ...of macular edema, which itself evolves with a temporal ... See full document

... Macular edema is the most frequent cause of visual impairment in patients with ...for macular edema secondary to BRVO that was used for patients affected for longer than 3 ... See full document

... recalcitrant edema despite frequent anti-VEGF injections, but this requires further ...similar visual outcomes in the treat- ment groups compared with their respective control ...of visual recovery ... See full document

... 31 patients (20 women, 11 men; mean age was ...years). Patients received a mean of ...corrected visual acuity increased from ...of patients required reinjection(s) treatment for ME ... See full document

... central retinal thickness (CRT) . 249 µ m, and visual acuity worse than 6/12, who could come for regu- lar follow-up visits were invited to participate in the ...2011. Patients excluded from the ... See full document

... DCP ischemia on SS-OCTA were significant predictors of poor visual outcome; whereas FFA features that included macular edema and macular ischemia did not correlate with the vis- ... See full document

... both macular edema and visual acuity in patients with retinal vein ...in Patients with Macular Edema Secondary to Branch Retinal Vein ... See full document

... of macular edema besides BRVOME and DME, the restriction of the data to 1 month after IVB, and by the fact that characteristics were not matched between the two ...between visual acuity and ...and ... See full document

... on macular morphology and functions in eyes with macular edema (ME) second- ary to retinal vein ...best-corrected visual acuity (BCVA) and central retinal thickness ...36 ... See full document

... domized patients who underwent PPV for BRVO from September 2003 to October 2007 and completed a 5-year ...best-corrected visual acuity (BCVA) was ... See full document

... the patients with stable and worse visual acuities) was ...improved visual acuity, 4 (14.2%) had stable visual acuity, and 2 ...worse visual acuity compared with ...that patients ... See full document

... for macular edema secondary to ...All patients received complete infor- mation about the natural course of BRVO and advantages and disadvantages of the treatments available and chose the ...all ... See full document

... the patients enrolled in the two studies were slightly different in some aspects, likely due in part to the different countries and geographic regions where they were ...cally, visual gains among ... See full document

... Results of the BRAVO, CRUISE and GENEVA studies provide an assessment of the safety profile of ranibizu- mab and dexamethasone IVT in patients with RVO. Ranibizumab was generally well tolerated in BRAVO and CRUISE ... See full document